nihonkohden

Top Message

Contribution to the World through Our Business

Hirokazu Ogino,
Representative Director,
President and CEO
Since 1951, Nihon Kohden has strived to contribute to the world by fighting disease and improving health with advanced technology, as well as create a fulfilling life for employees. This has led to revolutionary technologies and high quality medical devices. Nihon Kohden was founded with just twelve members, but today employs over 5,000 staff as it continues to tackle healthcare challenges around the world.
The products developed by Nihon Kohden have been exported to more than 120 countries around the world, where they have been used in various healthcare settings to save the lives of countless patients.

To save the lives of as many patients as possible, Nihon Kohden has continually pursued  technological innovation and strived to create higher quality products.
The Company’s mission as a medical device manufacturer is to provide clinical value as well as value to patients.
Nihon Kohden’s strengths lie in its ability to create value for society, primarily through 1) the capacity to develop technologies rooted in medical practice; 2) a broad clientele base inside and outside Japan; 3) high-quality products and services, and the development, production, sales and service systems to support them; and 4) the strength of a brand cultivated over many years.

Aspiring toward Sustainable Growth

Over recent years, Nihon Kohden’s business environment has been undergoing a drastic change. We have been called upon to respond to change across a range of areas, including serious environmental issues, an aging society and a declining birthrate in advanced countries, and intensifying global competition. In such an age of upheaval, we have taken a wide range of initiatives across three key fields, Healthcare, Environment, and Corporate Activities, as outlined in our Mid-term CSR Plan, Sustainable Growth 2020, to ensure sustainable growth and enhanced corporate value.

Through our healthcare initiatives, we not only offer quality products and services that contribute to improving quality of medical care and ensuring safe and secure medical care throughout the care cycle, but also are involved in activities to widely disseminate Basic Life Support using AEDs (automated external defibrillators) both domestically and overseas.

Our environmental initiatives target long-term environmental goals to reduce carbon dioxide emissions in line with the Paris Agreement. To achieve this, we are targeting reductions from FY2013 levels of 12% by FY2020, 26% by FY2030, and 80% by FY2050, which we will achieve by offering environmentally friendly products and promoting cooperation across our supply chain.

In the area of corporate activities, Nihon Kohden has adopted a Company with an Audit & Supervisory Committee structure in 2016 and newly created a Nomination and Remuneration Committee to further enhance corporate governance. From June 2018, one-third of the Board of Directors are independent outside directors. Along with moves to expand our business globally, we are placing increasing importance on compliance initiatives. In 2017, in tandem with establishing our Anti-corruption Rules across the entire Nihon Kohden Group, we also introduced a global compliance program. Furthermore, to improve the work-life balance of our employees and enhance productivity, we are aggressively implementing Work Style Reforms. 

As a means of facing the challenge of the new age, we are working even harder to enhance sustainable growth and maximize Nihon Kohden’s potential.